PL4053160T3 - Polipeptyd ludzkiego kolagenu typu 17, sposób jego wytwarzania i zastosowanie - Google Patents

Polipeptyd ludzkiego kolagenu typu 17, sposób jego wytwarzania i zastosowanie

Info

Publication number
PL4053160T3
PL4053160T3 PL20881368.3T PL20881368T PL4053160T3 PL 4053160 T3 PL4053160 T3 PL 4053160T3 PL 20881368 T PL20881368 T PL 20881368T PL 4053160 T3 PL4053160 T3 PL 4053160T3
Authority
PL
Poland
Prior art keywords
production method
method therefor
human collagen
type polypeptide
polypeptide
Prior art date
Application number
PL20881368.3T
Other languages
English (en)
Inventor
Yun Zhu
Original Assignee
Shanxi Jinbo Bio-Pharmaceutical Co., Ltd.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Shanxi Jinbo Bio-Pharmaceutical Co., Ltd. filed Critical Shanxi Jinbo Bio-Pharmaceutical Co., Ltd.
Publication of PL4053160T3 publication Critical patent/PL4053160T3/pl

Links

Classifications

    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23LFOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L29/00Foods or foodstuffs containing additives; Preparation or treatment thereof
    • A23L29/20Foods or foodstuffs containing additives; Preparation or treatment thereof containing gelling or thickening agents
    • A23L29/275Foods or foodstuffs containing additives; Preparation or treatment thereof containing gelling or thickening agents of animal origin, e.g. chitin
    • A23L29/281Proteins, e.g. gelatin or collagen
    • A23L29/284Gelatin; Collagen
    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23LFOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/17Amino acids, peptides or proteins
    • A23L33/18Peptides; Protein hydrolysates
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides
    • A61K38/01Hydrolysed proteins; Derivatives thereof
    • A61K38/012Hydrolysed proteins; Derivatives thereof from animals
    • A61K38/014Hydrolysed proteins; Derivatives thereof from animals from connective tissue peptides, e.g. gelatin, collagen
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/64Proteins; Peptides; Derivatives or degradation products thereof
    • A61K8/65Collagen; Gelatin; Keratin; Derivatives or degradation products thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61LMETHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/14Macromolecular materials
    • A61L27/22Polypeptides or derivatives thereof, e.g. degradation products
    • A61L27/24Collagen
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61LMETHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L31/00Materials for other surgical articles, e.g. stents, stent-grafts, shunts, surgical drapes, guide wires, materials for adhesion prevention, occluding devices, surgical gloves, tissue fixation devices
    • A61L31/04Macromolecular materials
    • A61L31/043Proteins; Polypeptides; Degradation products thereof
    • A61L31/044Collagen
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00Drugs for dermatological disorders
    • A61P17/18Antioxidants, e.g. antiradicals
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61QSPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00Preparations for care of the skin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61QSPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00Preparations for care of the skin
    • A61Q19/08Anti-ageing preparations
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/78Connective tissue peptides, e.g. collagen, elastin, laminin, fibronectin, vitronectin or cold insoluble globulin [CIG]
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09Recombinant DNA-technology
    • C12N15/63Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/70Vectors or expression systems specially adapted for E. coli
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2800/00Nucleic acids vectors
    • C12N2800/22Vectors comprising a coding region that has been codon optimised for expression in a respective host
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02ATECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Zoology (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Medicinal Chemistry (AREA)
  • Biomedical Technology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Dermatology (AREA)
  • Wood Science & Technology (AREA)
  • General Engineering & Computer Science (AREA)
  • Biotechnology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Birds (AREA)
  • Toxicology (AREA)
  • Microbiology (AREA)
  • Plant Pathology (AREA)
  • Physics & Mathematics (AREA)
  • Nutrition Science (AREA)
  • Food Science & Technology (AREA)
  • Polymers & Plastics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Gerontology & Geriatric Medicine (AREA)
  • Mycology (AREA)
  • Immunology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Oral & Maxillofacial Surgery (AREA)
  • Vascular Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
PL20881368.3T 2019-10-31 2020-10-26 Polipeptyd ludzkiego kolagenu typu 17, sposób jego wytwarzania i zastosowanie PL4053160T3 (pl)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
CN201911051106.3A CN110845603B (zh) 2019-10-31 2019-10-31 人胶原蛋白17型多肽、其生产方法和用途
PCT/CN2020/123600 WO2021083072A1 (zh) 2019-10-31 2020-10-26 人胶原蛋白17型多肽、其生产方法和用途

Publications (1)

Publication Number Publication Date
PL4053160T3 true PL4053160T3 (pl) 2025-12-01

Family

ID=69598618

Family Applications (1)

Application Number Title Priority Date Filing Date
PL20881368.3T PL4053160T3 (pl) 2019-10-31 2020-10-26 Polipeptyd ludzkiego kolagenu typu 17, sposób jego wytwarzania i zastosowanie

Country Status (16)

Country Link
US (3) US12043657B2 (pl)
EP (1) EP4053160B1 (pl)
JP (1) JP7300060B2 (pl)
KR (1) KR102665118B1 (pl)
CN (1) CN110845603B (pl)
DK (1) DK4053160T3 (pl)
ES (1) ES3048007T3 (pl)
FI (1) FI4053160T3 (pl)
HR (1) HRP20251216T1 (pl)
LT (1) LT4053160T (pl)
PL (1) PL4053160T3 (pl)
PT (1) PT4053160T (pl)
RS (1) RS67278B1 (pl)
SI (1) SI4053160T1 (pl)
SM (1) SMT202500377T1 (pl)
WO (1) WO2021083072A1 (pl)

Families Citing this family (43)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN110845603B (zh) 2019-10-31 2021-07-02 山西锦波生物医药股份有限公司 人胶原蛋白17型多肽、其生产方法和用途
CN112359103B (zh) * 2020-11-10 2023-03-14 中国科学院动物研究所 人皮肤衰老的分子标志物和调控靶标及其应用
CN113185604B (zh) * 2021-05-13 2021-12-14 江苏创健医疗科技有限公司 一种重组人xvii型胶原蛋白、制备方法和应用
CN113621052B (zh) * 2021-08-23 2022-06-07 山西锦波生物医药股份有限公司 一种重组i型人源化胶原蛋白多肽及其制备方法和用途
CN114106151A (zh) * 2021-12-10 2022-03-01 中基惠诚科技有限公司 一种抗氧化活性胶原蛋白肽的制备方法
CN114940712B (zh) * 2022-06-01 2023-12-26 山西锦波生物医药股份有限公司 一种生物合成人体结构性材料的制备方法
CN116375847B (zh) * 2022-10-26 2025-06-13 江苏创健医疗科技股份有限公司 酵母重组xvii型人源化胶原蛋白及其制备方法
CN116270982A (zh) * 2023-02-09 2023-06-23 山西锦波生物医药股份有限公司 重组xvii型人源化胶原蛋白在乳腺癌治疗中的用途
CN116509764A (zh) * 2023-03-16 2023-08-01 守正创新生物科技(天津)有限公司 一种含有重组17型人胶原蛋白的酵母发酵产物滤液
CN116715754B (zh) * 2023-05-12 2024-03-12 山西锦波生物医药股份有限公司 多肽及其用途
CN116751282B (zh) * 2023-05-17 2024-07-12 博汇美萃生物工程技术(广东)有限公司 一种重组ⅹⅶ人源化胶原蛋白及其制备方法和应用
CN116640231B (zh) * 2023-06-09 2024-03-26 广州暨南大学医药生物技术研究开发中心有限公司 一种重组人源化17型胶原多肽及其制备方法
CN117024569B (zh) * 2023-07-18 2024-05-10 山西锦波生物医药股份有限公司 生物合成人体结构性材料viii型胶原蛋白的方法
CN116948015B (zh) * 2023-07-18 2024-07-05 山西锦波生物医药股份有限公司 生物合成人体结构性材料xxii型胶原蛋白的方法
CN118903389B (zh) * 2023-08-01 2026-02-03 山西锦波生物医药股份有限公司 重组xvii型人源化胶原蛋白在宫颈癌治疗中的用途
CN117230103B (zh) * 2023-09-25 2024-04-19 爱光生物医药(南昌)有限公司 17型人源化胶原蛋白及其蛋白支架、填充材料及应用
CN119462898A (zh) * 2023-12-05 2025-02-18 北京华熙荣熙生物技术研究有限公司 一种具有三螺旋结构的重组xvii型胶原蛋白及其应用
CN117843763B (zh) * 2024-01-08 2026-01-27 山西锦波生物医药股份有限公司 生物合成人体结构性材料xvii型胶原蛋白的方法
CN117964740B (zh) 2024-01-26 2025-09-05 深圳粒影生物科技有限公司 具有三螺旋结构的重组ⅹⅶ型胶原蛋白及其应用
CN117801096B (zh) * 2024-01-29 2024-07-02 河北纳科生物科技有限公司 一种水溶性重组人ⅹⅶ型胶原蛋白及其制备方法和应用
CN117986353B (zh) * 2024-02-02 2024-08-30 西安巨子生物基因技术股份有限公司 重组人xvii型胶原蛋白、其制备方法及应用
CN117866077B (zh) * 2024-03-13 2024-05-28 北京未名拾光生物技术有限公司 重组xvii型胶原蛋白及其表达体系
CN117986389B (zh) * 2024-04-02 2024-06-07 百肽德医药生物科技(广东)有限公司 一种重组人源化xvii型胶原蛋白、制备方法及应用
CN118240066B (zh) * 2024-05-20 2024-08-13 深圳粒影生物科技有限公司 一种具有三螺旋结构的重组ⅹⅶ型胶原蛋白及其应用
CN118388634B (zh) * 2024-06-12 2025-03-25 山东美瑞生物技术有限公司 一种重组人源ⅵ+xvⅱ胶原蛋白及其制备方法
CN118324899B (zh) * 2024-06-13 2024-08-20 江苏亨瑞生物医药科技有限公司 一种重组xvii型人源化胶原蛋白、制备方法及其应用
CN118530338B (zh) * 2024-06-17 2025-06-10 西安巨子生物基因技术股份有限公司 具有促毛囊生长作用的重组人xvii型胶原蛋白及其应用
CN118845524B (zh) * 2024-07-10 2025-05-13 广州小姿电子商务有限公司 一种淡纹紧致三重活性胶原组合物及其制备方法和应用
CN119390816B (zh) * 2024-08-09 2026-03-27 山西锦波生物医药股份有限公司 一种新型重组人源化胶原蛋白水凝胶制备方法
CN118994374A (zh) * 2024-08-21 2024-11-22 江苏亨瑞生物医药科技有限公司 一种重组人源化xvii型胶原蛋白及其制备方法
CN119219762B (zh) * 2024-09-27 2025-07-15 浙江触奇生物科技有限公司 一种重组人xvii型胶原蛋白及其制备方法、应用
CN119264242A (zh) * 2024-10-11 2025-01-07 常州泰美瑞生物科技有限公司 一种重组xvii型胶原蛋白及其制备方法和应用
CN118955691B (zh) * 2024-10-21 2025-01-28 杭州凯曼健康科技有限公司 重组人源化xvii型胶原蛋白及其制备方法和应用
CN119548617B (zh) * 2024-11-25 2025-08-15 山西锦波生物医药股份有限公司 重组xvii型人源化胶原蛋白的新用途
CN119751646B (zh) * 2024-12-31 2025-12-02 江苏创健医疗科技股份有限公司 高稳定性的重组ⅹⅶ型胶原蛋白及其构建方法和应用
CN119798413B (zh) * 2024-12-31 2026-04-21 西安巨子生物基因技术股份有限公司 重组人xvii型胶原蛋白、其制备方法及应用
CN119930841B (zh) * 2025-01-16 2025-09-23 珠海市柏瑞医药科技有限公司 重组人源17型胶原贻贝粘蛋白多肽及其制备方法和用途
CN120284771B (zh) * 2025-03-12 2025-12-23 山西锦波生物医药股份有限公司 重组xvii型人源化胶原蛋白在防脱和生发中的应用
CN119978110B (zh) * 2025-04-15 2025-08-05 广州市暨源生物科技有限公司 一种具有透皮效果的重组17型胶原蛋白及其制备方法和应用
CN120248093B (zh) * 2025-06-04 2025-12-26 浙江暨北生物科技有限公司 重组a型人源化xvii型胶原蛋白及其构建与应用
CN120309715A (zh) * 2025-06-16 2025-07-15 杭州凯曼健康科技有限公司 重组人源化xvii型胶原蛋白及其制备方法和应用
CN120699168B (zh) * 2025-07-07 2026-02-03 中国科学技术大学先进技术研究院 一种多效修复型胶原蛋白及其应用
CN121064317B (zh) * 2025-11-10 2026-03-20 上海昱菘生物科技有限公司 一种人源化胶原蛋白ⅹⅶ型多肽及其制备方法和应用

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU3395900A (en) 1999-03-12 2000-10-04 Human Genome Sciences, Inc. Human lung cancer associated gene sequences and polypeptides
US20040142325A1 (en) 2001-09-14 2004-07-22 Liat Mintz Methods and systems for annotating biomolecular sequences
GB2485385A (en) * 2010-11-12 2012-05-16 Univ Manchester Trimeric fusion protein comprising collagen and a prokaryotic/ viral trimerisation domain
WO2012137970A1 (ja) * 2011-04-08 2012-10-11 国立大学法人大阪大学 改変ラミニンおよびその利用
IT201700104587A1 (it) 2017-09-19 2019-03-19 Holostem Terapie Avanzate S R L Usi terapeutici di lembi di cellule geneticamente modificate
US11732029B2 (en) * 2017-11-13 2023-08-22 The University Chicago Methods and compositions for the treatment of wounds
CN108822209A (zh) * 2018-07-06 2018-11-16 山西锦波生物医药股份有限公司 多肽、其生产方法和用途
CN109293783B (zh) * 2018-10-25 2019-10-11 山西锦波生物医药股份有限公司 多肽、其生产方法和用途
CN110845603B (zh) 2019-10-31 2021-07-02 山西锦波生物医药股份有限公司 人胶原蛋白17型多肽、其生产方法和用途

Also Published As

Publication number Publication date
CN110845603B (zh) 2021-07-02
JP2023504341A (ja) 2023-02-03
SMT202500377T1 (it) 2025-11-10
KR102665118B1 (ko) 2024-05-13
US20240301035A1 (en) 2024-09-12
RS67278B1 (sr) 2025-10-31
KR20220058619A (ko) 2022-05-09
US20220348639A1 (en) 2022-11-03
HRP20251216T1 (hr) 2025-12-05
EP4053160B1 (en) 2025-09-10
ES3048007T3 (en) 2025-12-05
SI4053160T1 (sl) 2025-11-28
PT4053160T (pt) 2025-10-09
US20240309067A1 (en) 2024-09-19
LT4053160T (lt) 2025-11-10
BR112022004900A2 (pt) 2022-06-28
DK4053160T3 (da) 2025-10-06
CN110845603A (zh) 2020-02-28
JP7300060B2 (ja) 2023-06-28
US12428468B2 (en) 2025-09-30
US12043657B2 (en) 2024-07-23
EP4053160A1 (en) 2022-09-07
WO2021083072A1 (zh) 2021-05-06
US12428469B2 (en) 2025-09-30
EP4053160A4 (en) 2023-11-01
FI4053160T3 (fi) 2025-10-17

Similar Documents

Publication Publication Date Title
PL4053160T3 (pl) Polipeptyd ludzkiego kolagenu typu 17, sposób jego wytwarzania i zastosowanie
PT3793008T (pt) Material de elétrodo positivo, método para a sua preparação, e sua utilização
PL4119573T3 (pl) Rekombinowany ludzki kolagen typu XVII, metoda jego przygotowania oraz zastosowanie
GB202407559D0 (en) Recombinant collagen, preparation method therefor and application thereof
EP3620474A4 (en) HUMAN FIBROBLASTS GROWTH FACTOR 21 (HFGF21) FUSION PROTEIN, METHOD OF PREPARATION AND USE
PL3660045T3 (pl) Polipeptyd, sposób jego wytwarzania i zastosowanie tego polipeptydu
SG10201913726PA (en) Novel polypeptide and method of producing imp using the same
ZA201903357B (en) Novel polypeptide and method of producing imp using the same
SG11202001889YA (en) Cell aggregate including retinal tissue and production method therefor
EP4081576A4 (en) DOUBLE CROSSLINKED HYDROGEL AND PROCESS FOR ITS PRODUCTION
IL287318A (en) Materials and methods for the production of proteins
EP3979873A4 (en) SILK-STIMULATED COLLAGEN PRODUCTION AND METHODS OF USE THEREOF
EP3705140A4 (en) MEDICAL MATERIAL PRODUCED BY USING COLLAGEN AND PROCESS FOR THE PRODUCTION OF THE SAME
SG11202009563QA (en) Polyurethane gel material, polyurethane gel, pseudo-biomaterial, and producing method of polyurethane gel
ZA202101260B (en) Long-acting recombinant glp1-fc-cd47 protein, preparation method and use thereof
SG11202111462VA (en) Asx-specific protein ligases and uses thereof
IL279552A (en) The hemostatic composition and method for its preparation
SG11202108373PA (en) External agent for skin or mucous membrane and production method thereof, and base for external agent for skin or mucous membrane
GB2600592B (en) Polypeptide and use thereof
EP4063400A4 (en) SULFHYDRYL MODIFIED HYALURONIC ACID, METHOD OF PRODUCTION THEREOF AND USE THEREOF
PL3854423T3 (pl) Sztuczny materiał do naprawy skóry i sposób jego otrzymywania
GB201906900D0 (en) Method and system using mapped emotions
IL285368A (en) Protein-based hydrogel
SG11202009566VA (en) Polyurethane gel material, polyurethane gel, pseudo-biomaterial, and producing method of polyurethane gel
SG11202001216WA (en) Production method for medical and cosmetic material, and medical and cosmetic material